

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TEVA | NYSE | USD | Real-time | |
TEVAN | Mexico | MXN | Delayed | |
TEVAy | TradeGate | EUR | Delayed | |
TEVA | Tel Aviv | ILS | Delayed |
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), today announced 12 presentations across its neuroscience portfolio featured at the Psych Congress Elevate...
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades for Rambus, WEC Energy, Dynatrace, and Teva Pharma.InvestingPro subscribers got this news before...
Investing.com - Teva ADR (NYSE: TEVA) reported first quarter EPS of $0.40, $0.15 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $3.7B versus the consensus estimate of...
By Blake Brittain (Reuters) - Vanda (NASDAQ:VNDA) Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration...
By Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration on Friday approved Pfizer Inc (NYSE:PFE)'s nasal spray for migraine, giving patients access to a potentially fast-acting...
Teva Pharma (TEVA) reported Q4 EPS of $0.71, in-line with the analyst estimate of $0.71. Revenue for the quarter came in at $3.9 billion versus the consensus estimate of $3.88 billion. GUIDANCE: Teva...
Investing.com - Teva ADR (NYSE: TEVA) reported fourth quarter EPS of $0.71, in line with the analyst estimate of $0.71. Revenue for the quarter came in at $3.9B versus the consensus estimate of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review